Skip to content

Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation

Comparative Clinical and Histological Investigation of Graft Integration Following Piezosurgically Retrieved Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation - Prospective Randomized Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04811768
Enrollment
40
Registered
2021-03-23
Start date
2017-03-01
Completion date
2018-05-30
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus Augmentation

Keywords

maxillary sinus, xenogeneic graft, collagen membrane, lateral bony wall repositioning, piezoelectric surgery

Brief summary

The aim of the present prospective randomized controlled study is to clinically and histologically investigate the safety and efficacy of bony wall repositioning compared to rotary window preparation with membrane coverage in maxillary sinus floor augmentation.

Detailed description

40 patients were randomly divided in two study groups after radiological and clinical evaluation. Both groups received bone grafting by a xenogeneic bone substitute (BSM, cerabone, botiss biomaterials GmbH, Zossen, Germany) using the lateral approach. In the bony wall group (BW), following piezosurgery the retrieved bony wall was repositioned. In the collagen membrane group (CM), the lateral window was created by rotary instruments, covered via a native collagen membrane (collprotect, botiss biomaterials GmbH, Zossen, Germany). After 6 months, biopsies were taken to analyze both approaches in terms of new bone formation. Duration of treatment, the number of perforations, postoperative patient discomfort were registered. Established histopathological analysis and histomorphometrical measurements to analyze the tissue reactions and the tissue distribution, i.e., the fractions of newly formed bone tissue (NB), of remaining bone substitute material (BSM) and connective tissue (CT), were conducted.

Interventions

PROCEDUREMaxillary sinus augmentation

The surgery was performed under local anaesthesia in both groups, lateral window preparation and window coverage was carried out based on randomization.

Sponsors

NSK Europe GmbH
CollaboratorINDUSTRY
Botiss Medical AG
CollaboratorOTHER
Institut Straumann AG
CollaboratorINDUSTRY
Dicomlab Kft.
CollaboratorUNKNOWN
Hungarian Human Resources Development Operational Program (EFOP-3.6.2-16-2017-00006)
CollaboratorUNKNOWN
Excellence Program of the Ministry for Innovation and Technology in Hungary
CollaboratorUNKNOWN
Semmelweis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Histology analysis was performed blinded, randomization sequence was revealed after histomorphometry

Intervention model description

40 patients underwent sinus floor augmentation - 20 patients treated by bony wall repositioning, 20 patients treated by collagen membrane coverage

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* at least one missing maxillary premolar or molar * at least 7 mm crestal bone width confirmed by preoperative ConeBeam Tomography (CBCT) * maximally 5 mm residual bone height at the sinus floor confirmed by preoperative ConeBeam Tomography (CBCT) * full mouth plaque and bleeding scores (FMPS and FMBS) \<20% * satisfactory patient compliance (e.g. to participate in follow-up procedures) * signed informed consent.

Exclusion criteria

* clinically relevant diseases (e.g.: diabetes, rheumatism cancer) * untreated periodontitis * systemic steroid use * bisphosphonate use * acute or chronic inflammatory processes * previous endoscopic sinus surgery * previous sinus floor elevation * GBR-treatment at the study site * GTR-treatment at the study site * tooth removal within 6 weeks prior to surgery

Design outcomes

Primary

MeasureTime frameDescription
Duration of surgeryDuring smaxillary sinus augmentationRecorded in minutes

Secondary

MeasureTime frameDescription
Duration of lateral window preparationDuring maxillary sinus augmentationRecorded in minutes
Duration of mucosa preparationDuring maxillary sinus augmentationRecorded in minutes
Visual Analog Scale (Minimum value 0, Maximum value 100, the higher the worse)12 hours postoperativelyMeasurement of patient discomfort
Postoperative Edema Score2 days postoperativelyMeasurement of swelling
Histomorphometrical analysisFollowing reentry 6 months after maxillary sinus augmentationPercentage of newly formed bone, bone substitute and connective tissue

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026